comparative cardiovascular effects thiazolidinediones systematic review meta-analysis observational studies abstract objective determine comparative effects thiazolidinediones rosiglitazone pioglitazone myocardial infarction congestive heart failure mortality patients type num diabetes design systematic review meta-analysis observational studies data sources searches medline embase september num study selection observational studies directly compared risk cardiovascular outcomes rosiglitazone pioglitazone patients type num diabetes mellitus included data extraction random effects meta-analysis inverse variance method calculate odds ratios cardiovascular outcomes thiazolidinedione num statistic assess statistical heterogeneity results cardiovascular outcomes num observational studies num case-control studies num retrospective cohort studies including num num thiazolidinedione users evaluated detailed review num citations compared pioglitazone rosiglitazone statistically significant increase odds myocardial infarction num studies odds ratio num num confidence interval num num num num congestive heart failure num num num num num num death num num num num num num numbers needed treat harm nnh depending population risk suggest num excess myocardial infarctions num excess cases heart failure num excess deaths num num patients receive rosiglitazone pioglitazone conclusion patients type num diabetes rosiglitazone significantly higher odds congestive heart failure myocardial infarction death relative pioglitazone real world settings 
